In colorectal cancer cells, p21 was also upregulated by celecoxib [47], and upregulation of DR5 by celecoxib was reported in non-small-cell lung cancer as well as in hepatocellular carcinoma cells [40,48]. Here, TNFRSF10B is linked to hepatocellular carcinoma.